Vial Adaptors For Reconstitution Drug Market Size (2024 - 2029)

Vial Adaptors For Reconstitution Drug Market Analysis

The Vial Adaptors For Reconstitution Drug Market is expected to register a CAGR of 7.30% during the forecast period.

Factors such as the increasing prevalence of chronic and infectious diseases, the rising geriatric population, and increasing awareness of the advantages of vial adaptors are expected to boost market growth during the forecast period.

The growing burden of chronic diseases such as multiple sclerosis, diabetes, and rheumatoid arthritis is expected to boost the need for effective drugs, propelling the demand for vial adaptors to enable the safe, rapid transfer and reconstitution of drugs between vials. For instance, according to the World Health Organization’s August 2023 update, more than 2.8 million people globally have MS, including 1 million in the United States in 2022.

Additionally, as per 2022 updated data published by the International Diabetes Federation, the number of population expected to be diagnosed with diabetes will reach 643 million and 784 million by 2030 and 2045, respectively. Thus, the expected increase in the diabetic population fuels the need for vial adaptors for reconstituting or mixing insulin or other injectable medications, thereby boosting market growth.

Various research studies were conducted to estimate cancer incidence worldwide. For instance, per an article published in the Indian Journal of Medical Research in March 2023, India recorded an estimated 1 million incident cases of cancer in 2022. In addition, the incidence of cancer cases is estimated to increase by 12.8% in 2025 compared to the previous year. The rising number of cancer patients necessitates chemotherapy drugs, driving the demand for vial adaptors. These adaptors are crucial for preparing and administering injectable chemotherapy drugs, especially as many of these drugs are in powdered form within vials. This is anticipated to bolster market growth during the forecast period.

Additionally, the number of populations suffering from autoimmune diseases is increasing due to changes in environmental factors. For instance, according to 2023 data published by the European Congress of Rheumatology (EULAR), one in 10 individuals in the United Kingdom suffered from autoimmune diseases, and these cases increased over time. Vial adaptors play a crucial role in preparing and administering injectable drugs. This is mainly for autoimmune drugs like monoclonal antibodies and other biological therapies, which are typically supplied in vials as lyophilized powders or concentrated solutions. Given that these drugs often need to be reconstituted with a diluent before being administered, the market’s demand for vial adaptors is expected to increase during the forecast period.

The burden of metabolic disorders is increasing worldwide due to behavioral changes in lifestyles, leading to long-term health problems and expensive treatments. For instance, as per the World Obesity Atlas 2023, the prevalence of obesity (BMI ≥30kg/m²) alone was anticipated to rise from 14% to 24% among the population from 2020 to 2035, affecting nearly 2 billion adults, children, and adolescents by 2035. The overweight population has a higher risk of developing metabolic conditions due to high cholesterol, insulin resistance, and high blood pressure, fueling the demand for effective drugs. The availability of peptide hormones or receptor agonists in powder form raises the demand for safe and sterile transfer of the diluent into the drug vial, which is expected to propel the demand for vial adaptors in the market during the forecast period.

Therefore, owing to factors such as the growing burden of chronic and infectious diseases, the market studied is expected to grow during the forecast period. However, the availability of substitutes is expected to hinder the growth of the market during the forecast period.

Vial Adaptors For Reconstitution Drug Industry Segmentation

As per the scope of the report, vial adapters are a cost-effective solution for the safe and rapid transfer and reconstitution of drugs between vials and syringes. Adaptors enable the optimal aspiration of mixed and reconstituted drugs.

The vial adaptors for the reconstitution drug market are segmented by material type, therapeutic area, and geography. By material type, the market is segmented into polycarbonate, silicon, polyethylene, and other material types. In terms of therapeutic areas, the market is bifurcated into autoimmune diseases, infectious diseases, metabolic conditions, and other therapeutic areas. By geography, the market is divided into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (USD) for the above segments.